SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Balincan USA, Inc. (BCNN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 17/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BCNN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.02
Book Value / Share$0.00
Revenue / Share$0.01
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2006 |
$-61.60 |
$1.59M |
$-2M |
-125.9% |
| 2007 |
$-0.44 |
$0.00 |
$-165K |
- |
| 2008 |
$-0.17 |
$0.00 |
$-121K |
- |
| 2009 |
$-5.29 |
$1.37K |
$-23.44M |
-1708527.7% |
| 2015 |
$-0.03 |
$0.00 |
$-468K |
- |
| 2019 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2020 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2021 |
$-0.01 |
$2.77M |
$-204K |
-7.4% |
| 2022 |
$0.01 |
$2.04M |
$709.07K |
34.8% |
| 2023 |
$-0.02 |
$2.69M |
$-3.75M |
-139.3% |
